| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0735-1097(97)00129-0 |
| P698 | PubMed publication ID | 9207626 |
| P2093 | author name string | M Yamamoto | |
| K Ishikawa | |||
| K Kawano | |||
| Y Kawai | |||
| N Aoki | |||
| A Yanagisawa | |||
| A Maki | |||
| I Aoki | |||
| M Homori | |||
| K Shimoyama | |||
| P2860 | cites work | LDL particle size distribution. Results from the Framingham Offspring Study | Q33193120 |
| Platelet hypersensitivity induced by cholesterol incorporation | Q34475652 | ||
| Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis | Q35360356 | ||
| Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism | Q37486429 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Normal levels of fibrinopeptide A in patients with primary hyperlipidemia | Q41675381 | ||
| Pharmacokinetics of pravastatin in elderly versus young men and women | Q42608089 | ||
| Cholestyramine treatment of type IIa hypercholesterolaemia normalizes platelet reactivity against prostacyclin | Q44087571 | ||
| Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients | Q46125635 | ||
| Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation | Q46415777 | ||
| Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors | Q46507614 | ||
| Increased plasma antithrombin III level in hyperlipidemic subjects | Q57225692 | ||
| 58 Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica | Q58421781 | ||
| Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients | Q67492341 | ||
| Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins | Q67508036 | ||
| Platelet-dependent thrombin generation after in vitro fibrinolytic treatment | Q68055195 | ||
| Increased thromboxane biosynthesis in type IIa hypercholesterolemia | Q68105507 | ||
| Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia | Q68486298 | ||
| Platelet function in hyperlipoproteinemia | Q68676427 | ||
| The use of sulodexide in the treatment of peripheral vasculopathy accompanying metabolic diseases. Controlled study in hyperlipidemic and diabetic subjects | Q68868724 | ||
| Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients | Q69554396 | ||
| Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia | Q70026021 | ||
| Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs | Q70122379 | ||
| Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia | Q70538637 | ||
| The effect of variable fat diets and cholesterol-lowering drugs on Antithrombin III levels in hyperlipoproteinemic and normal subjects | Q71016339 | ||
| Effect of cholesterol on production of thromboxane b2 by platelets in vitro | Q71128180 | ||
| Relationship of triglyceride levels to thrombosis in patients with coronary artery disease | Q71677864 | ||
| Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction | Q72721569 | ||
| Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a | Q72913243 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 91-96 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Platelet-dependent thrombin generation in patients with hyperlipidemia | |
| P478 | volume | 30 |
| Q33862438 | Atheromas of the thoracic aorta: clinical and therapeutic update |
| Q42416773 | Curcuma oil ameliorates insulin resistance & associated thrombotic complications in hamster & rat |
| Q24646366 | Defective thrombus formation in mice lacking coagulation factor XII |
| Q36567704 | Determination of normal range of bleeding time in rural and urban residents of Borujerd, Iran: A pilot study |
| Q90677982 | Direct activation of platelets by addition of CaCl2 leads coagulation of platelet-rich plasma |
| Q73665593 | Effect of statin therapy on restenosis after coronary stent implantation |
| Q34106488 | Effects of HMG-CoA reductase inhibitor on hemostasis |
| Q35200997 | Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes |
| Q52218975 | Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia. |
| Q35551180 | Noncholesterol-Lowering Effects of Statins |
| Q34373712 | Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation |
| Q58076948 | Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo |
| Q73163227 | Platelet-induced thrombin generation time II (PITT II). A modified global coagulation test to monitor prophylactic anticoagulation with vitamin K antagonists? |
| Q39069187 | Pleiotropic Effects of Statins on the Cardiovascular System |
| Q33859347 | Prevention of coronary heart disease. Part I. Primary prevention |
| Q35077221 | Prevention of stroke and dementia with statins: Effects beyond lipid lowering |
| Q42737361 | Prothrombinase formation at the site of microvascular injury and aspirin resistance: the effect of simvastatin |
| Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
| Q37276466 | Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? |
| Q64248997 | The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia |
| Q33818141 | The evolving role of statins in the management of atherosclerosis |
| Q36059492 | The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology |
Search more.